Avalo Therapeutics Analyst Ratings
Avalo Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/08/2023 | -13.29% | Jefferies | → $3 | Downgrades | Hold → Underperform |
| 03/03/2022 | -78.32% | Jefferies | $5 → $0.75 | Downgrades | Buy → Hold |
| 03/03/2022 | 15.61% | RBC Capital | $5 → $4 | Maintains | Outperform |
| 09/24/2021 | 73.41% | RBC Capital | → $6 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 02/08/2023 | -13.29% | 杰富瑞 | →$3 | 评级下调 | 持有→表现不佳 |
| 03/03/2022 | -78.32% | 杰富瑞 | $5→$0.75 | 评级下调 | 购买→Hold |
| 03/03/2022 | 15.61% | 加拿大皇家银行资本 | $5→$4 | 维护 | 跑赢大盘 |
| 09/24/2021 | 73.41% | 加拿大皇家银行资本 | →$6 | 开始承保 | →跑赢大盘 |
What is the target price for Avalo Therapeutics (AVTX)?
阿瓦洛治疗公司(AVTX)的目标价格是多少？
The latest price target for Avalo Therapeutics (NASDAQ: AVTX) was reported by Jefferies on February 8, 2023. The analyst firm set a price target for $3.00 expecting AVTX to fall to within 12 months (a possible -13.29% downside). 3 analyst firms have reported ratings in the last year.
杰富瑞于2023年2月8日报道了阿瓦洛治疗公司(纳斯达克：AVTX)的最新目标价。这家分析公司将目标价定为3.00美元，预计AVTX将在12个月内下跌(跌幅可能为-13.29%)。3家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Avalo Therapeutics (AVTX)?
Avalo治疗公司(AVTX)的最新分析师评级是什么？
The latest analyst rating for Avalo Therapeutics (NASDAQ: AVTX) was provided by Jefferies, and Avalo Therapeutics downgraded their underperform rating.
杰富瑞提供了对阿瓦洛治疗公司(纳斯达克代码：AVTX)的最新分析师评级，阿瓦洛治疗公司下调了其表现不佳的评级。
When is the next analyst rating going to be posted or updated for Avalo Therapeutics (AVTX)?
Avalo治疗公司(AVTX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avalo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avalo Therapeutics was filed on February 8, 2023 so you should expect the next rating to be made available sometime around February 8, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与阿瓦洛治疗公司的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Avalo治疗公司的上一次评级是在2023年2月8日提交的，所以你应该预计下一次评级将在2024年2月8日左右提供。
Is the Analyst Rating Avalo Therapeutics (AVTX) correct?
分析师对Avalo Treeutics(AVTX)的评级正确吗？
While ratings are subjective and will change, the latest Avalo Therapeutics (AVTX) rating was a downgraded with a price target of $0.00 to $3.00. The current price Avalo Therapeutics (AVTX) is trading at is $3.46, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Avalo治疗公司(AVTX)评级被下调，目标价为0.00美元至3.00美元。Avalo治疗公司(AVTX)目前的交易价格为3.46美元，超出了分析师的预测范围。